Subject: endpoint - показатель?? med. Контекст:Whichever type of study is carried out, it was agreed that standardized multiparameter measurements are necessary, to be combined with factors not overtly immunological, ie. biological, functional and cognitive markers of ageing (including ADL, IADL, MMSE, GDS). If not using mortality as a robust but perhaps less than optimally informative endpoint, what clinical parameters can be utilised to assess the impact of immunosenescence? The above-mentioned functional tests could be good endpoints in elderly subjects. Вопрос 1: Являются ли ADL, IADL, MMSE, GDS функциональными тестами? (расшифровывать не надо). Вопрос 2: "robust endpoint" в данном случае может ли быть "надежным показателем", а "less than optimally informative endpoint" - "малоинформативным показателем"?? |
1) да 2) можно + устойчивый к систематическим ошибкам |
thnx |
You need to be logged in to post in the forum |